These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16895524)

  • 21. Hepatocyte nuclear factor (HNF) 4α transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice.
    Ning M; Koh KH; Pan X; Jeong H
    Biochem Pharmacol; 2015 Mar; 94(1):46-52. PubMed ID: 25598084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two novel cis-elements involved in hepatocyte nuclear factor 4α regulation of acyl-coenzyme A:cholesterol acyltransferase 2 expression.
    Zhang Z; Liu J; Xi Y; Yang R; Chen H; Li Z; Liu D; Liang C
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):162-71. PubMed ID: 22155889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
    Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.
    Wu Q; Liu HO; Liu YD; Liu WS; Pan D; Zhang WJ; Yang L; Fu Q; Xu JJ; Gu JX
    J Biol Chem; 2015 Jan; 290(2):1170-85. PubMed ID: 25422324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ.
    Sasaki S; Urabe M; Maeda T; Suzuki J; Irie R; Suzuki M; Tomaru Y; Sakaguchi M; Gonzalez FJ; Inoue Y
    Mol Cell Biol; 2018 Dec; 38(24):. PubMed ID: 30224520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
    Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
    Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Underexpressed coactivators PGC1alpha and SRC1 impair hepatocyte nuclear factor 4 alpha function and promote dedifferentiation in human hepatoma cells.
    Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
    J Biol Chem; 2006 Oct; 281(40):29840-9. PubMed ID: 16891307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.
    Liu L; Chen X; Xie S; Zhang C; Qiu Z; Zhu F
    Hepatology; 2012 Nov; 56(5):1760-9. PubMed ID: 22576474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exo70 is transcriptionally up-regulated by hepatic nuclear factor 4α and contributes to cell cycle control in hepatoma cells.
    Zhao Y; Hou J; Mi P; Mao L; Xu L; Zhang Y; Xiao L; Cao H; Zhang W; Zhang B; Song G; Hu T; Zhan YY
    Oncotarget; 2016 Feb; 7(8):9150-62. PubMed ID: 26848864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
    Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
    Arima T; Nakao K; Nakata K; Ishikawa H; Ichikawa T; Hamasaki K; Ishii N; Eguchi K
    Int J Mol Med; 2002 Apr; 9(4):397-400. PubMed ID: 11891535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
    Yin C; Lin Y; Zhang X; Chen YX; Zeng X; Yue HY; Hou JL; Deng X; Zhang JP; Han ZG; Xie WF
    Hepatology; 2008 Nov; 48(5):1528-39. PubMed ID: 18925631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of hepatocyte nuclear factor 4α in controlling copper-responsive transcription.
    Song MO; Freedman JH
    Biochim Biophys Acta; 2011 Jan; 1813(1):102-8. PubMed ID: 20875833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of Egr-1 in HGF-induced elevation of the human 5alpha-R1 gene in human hepatocellular carcinoma cells.
    Rui C; Li C; Xu W; Zhan Y; Li Y; Yang X
    Biochem J; 2008 Apr; 411(2):379-86. PubMed ID: 18215136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
    Yin C; Wang PQ; Xu WP; Yang Y; Zhang Q; Ning BF; Zhang PP; Zhou WP; Xie WF; Chen WS; Zhang X
    Hepatology; 2013 Dec; 58(6):1964-76. PubMed ID: 23775631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
    Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
    Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
    Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
    Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.